Literature DB >> 15254947

Vascular hemichorea/hemiballism and topiramate.

Emilia Mabel Gatto1, Claudia Uribe Roca1, Gabriela Raina1, Marcelo Gorja1, Silvia Folgar1, Federico E Micheli1.   

Abstract

Although vascular hemichorea/hemiballism (HC/HB) has been reported to be self-limited, in some cases, it can be irreversible and severely disabling. The standard treatment includes typical and atypical neuroleptics and GABA-mimetic drugs. Topiramate is a new antiepileptic drug possessing a complex mechanism of action, including the enhancement of GABA-mediated inhibition. We describe a 71-year-old patient with HC/HB who markedly improved after topiramate treatment. Copyright 2004 Movement Disorder Society

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15254947     DOI： 10.1002/mds.20086

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


  8 in total

1.  Improvement of cervico-trunco-brachial segmental dystonia with topiramate.

Authors:  Spiridon Papapetropoulos; Carlos Singer
Journal:  J Neurol       Date:  2005-11-22       Impact factor: 4.849

2.  Neurophysiological Features Of Hemiballism.

Authors:  Yi-Cheng Tai; Yun Wo Katie Yin; Ainhi D Ha; Robert Adam; Neil Mahant; Carolyn M Sue; Victor S C Fung
Journal:  Mov Disord Clin Pract       Date:  2016-05-19

3.  Bilateral chorea/ballismus: detection and management of a rare complication of non-ketotic hyperglycaemia.

Authors:  Venkata Sunil Bendi; Abhishek Matta; Diego Torres-Russotto; James Shou
Journal:  BMJ Case Rep       Date:  2018-06-19

Review 4.  Antiseizure Drugs and Movement Disorders.

Authors:  Michel Sáenz-Farret; Marina A J Tijssen; Dawn Eliashiv; Robert S Fisher; Kapil Sethi; Alfonso Fasano
Journal:  CNS Drugs       Date:  2022-07-21       Impact factor: 6.497

5.  Use of antiepileptic drugs for hyperkinetic movement disorders.

Authors:  A Siniscalchi; L Gallelli; G De Sarro
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

6.  A case of vascular hemichorea responding to topiramate.

Authors:  Jee-Ae Kim; San Jung; Min-Ju Kim; Seok-Beom Kwon; Sung-Hee Hwang; Ki-Han Kwon
Journal:  J Mov Disord       Date:  2009-10-30

Review 7.  Post-stroke dyskinesias.

Authors:  Mohammad Obadah Nakawah; Eugene C Lai
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-07       Impact factor: 2.570

8.  Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management.

Authors:  Antonio Siniscalchi; Luca Gallelli; Angelo Labate; Giovanni Malferrari; Caterina Palleria; Giovambattista De Sarro
Journal:  Curr Neuropharmacol       Date:  2012-09       Impact factor: 7.363
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.